Innovative Technology Offering QATCH Technologies develops a unique sensor technology that de-risks early-stage biopharmaceutical development, presenting a compelling solution for biotech and pharmaceutical companies seeking to streamline drug development processes.

Focus on Biotech Startups With a small team and close ties to academic research at Duke University, QATCH is well-positioned to partner with emerging biotech firms looking for innovative tools to accelerate their preclinical pipelines.

Growth and Revenue Potential Having generated between 1 and 10 million dollars in revenue and securing initial funding, QATCH presents an opportunity for strategic investments and sales to companies aiming to expand their analytical capabilities in biopharma.

Potential Market Expansion The company's focus on prescreening injectability and manufacturability aligns with the increasing demand for precision medicine and safer, more efficient drug formulations, opening avenues for sales to contract research organizations and pharma manufacturers.

Tech-Driven Solutions Utilizing modern web technologies and analytics tools, QATCH demonstrates a tech-savvy approach, which can be leveraged to offer integrated data solutions and ongoing support to clients investing in digital transformation within biotech R&D.